Tandem Diabetes Care
TNDM
TNDM
295 hedge funds and large institutions have $2.89B invested in Tandem Diabetes Care in 2022 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 109 increasing their positions, 102 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 48
4% less capital invested
Capital invested by funds: $3.02B → $2.89B (-$134M)
1% less funds holding
Funds holding: 299 → 295 (-4)
Holders
295
Holding in Top 10
4
Calls
$19.5M
Puts
$10.1M
Top Buyers
| 1 | +$55.9M | |
| 2 | +$54M | |
| 3 | +$39.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.3M |
| 5 |
Millennium Management
New York
|
+$24.5M |
Top Sellers
| 1 | -$51.2M | |
| 2 | -$29.6M | |
| 3 | -$26.1M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$24.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$20.4M |